Literature DB >> 32782097

Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments.

Asher Schranz1, Joshua A Barocas2.   

Abstract

Infective endocarditis associated with injection drug use (IDU-IE) is markedly increasing in the United States and Canada. Long-term outcomes are dismal and stem from insufficient substance use disorder treatment. In this review, we summarize the principles of antimicrobial and surgical management for infective endocarditis associated with injection drug use. We discuss approaches to opioid use disorder care and harm reduction in the inpatient setting and review opportunities to address preventable infections among persons injecting drugs. We highlight barriers to implementing optimal treatment and consider novel approaches that may reshape infective endocarditis associated with injection drug use treatment in coming years.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infective endocarditis; Injection drug use; Opioids; Substance use disorders

Mesh:

Substances:

Year:  2020        PMID: 32782097      PMCID: PMC7945002          DOI: 10.1016/j.idc.2020.06.004

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  75 in total

1.  Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna.

Authors:  Selma Tobudic; Christina Forstner; Heinz Burgmann; Heimo Lagler; Michael Ramharter; Christoph Steininger; Matthias G Vossen; Stefan Winkler; Florian Thalhammer
Journal:  Clin Infect Dis       Date:  2018-08-16       Impact factor: 9.079

2.  Attitudes and Approaches Towards Repeat Valve Surgery in Recurrent Injection Drug Use-associated Infective Endocarditis: A Qualitative Study.

Authors:  Margaret Hayden; Amber Moore
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 3.702

3.  French national cohort of first use of dalbavancin: A high proportion of off-label use.

Authors:  Aurélien Dinh; Clara Duran; Patricia Pavese; Lydie Khatchatourian; Boris Monnin; Alexandre Bleibtreu; Eric Denis; Cédric Etienne; Nicolas Rouanes; Rafael Mahieu; Frédérique Bouchand; Benjamin Davido; Romain Lotte; Philippe Cabaret; Fabrice Camou; Pascal Chavanet; Assi Assi; Silvia Limonta; Catherine Lechiche; Raphaëlle Riou; Johan Courjon; Gabriela Illes; Flore Lacassin-Beller; Eric Senneville
Journal:  Int J Antimicrob Agents       Date:  2019-08-07       Impact factor: 5.283

4.  In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.

Authors:  Tahaniyat Lalani; Vivian H Chu; Lawrence P Park; Enrico Cecchi; G Ralph Corey; Emanuele Durante-Mangoni; Vance G Fowler; David Gordon; Paolo Grossi; Margaret Hannan; Bruno Hoen; Patricia Muñoz; Hussien Rizk; Souha S Kanj; Christine Selton-Suty; Daniel J Sexton; Denis Spelman; Veronica Ravasio; Marie Françoise Tripodi; Andrew Wang
Journal:  JAMA Intern Med       Date:  2013-09-09       Impact factor: 21.873

5.  Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model.

Authors:  Laura C Fanucchi; Sharon L Walsh; Alice C Thornton; Michelle R Lofwall
Journal:  Prev Med       Date:  2019-06-26       Impact factor: 4.018

Review 6.  Harm reduction therapy: a practice-friendly review of research.

Authors:  Diane E Logan; G Alan Marlatt
Journal:  J Clin Psychol       Date:  2010-02

7.  Recidivism Is the Leading Cause of Death Among Intravenous Drug Users Who Underwent Cardiac Surgery for Infective Endocarditis.

Authors:  Max Jordan Nguemeni Tiako; Makoto Mori; Syed Usman Bin Mahmood; Kayoko Shioda; Abeel Mangi; James Yun; Arnar Geirsson
Journal:  Semin Thorac Cardiovasc Surg       Date:  2018-08-27

8.  Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections.

Authors:  Cassie L Stewart; Michelle S Turner; Jeremy J Frens; Cynthia B Snider; Jordan R Smith
Journal:  Infect Dis Ther       Date:  2017-04-06

9.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

10.  Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.

Authors:  Kinna Thakarar; Kristina E Rokas; F L Lucas; Spencer Powers; Elizabeth Andrews; Christina DeMatteo; Deirdre Mooney; Marcella H Sorg; August Valenti; Mylan Cohen
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240

View more
  2 in total

1.  "I have such a hard time hitting myself, I thought it'd be easier": perspectives of hospitalized patients on injecting drugs into vascular access devices.

Authors:  Hannah L Brooks; Ginetta Salvalaggio; Bernadette Pauly; Kathryn Dong; Tania Bubela; Marliss Taylor; Elaine Hyshka
Journal:  Harm Reduct J       Date:  2022-05-26

2.  Research on substance use disorders during the COVID-19 pandemic.

Authors:  Nora D Volkow; Carlos Blanco
Journal:  J Subst Abuse Treat       Date:  2021-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.